France Microfluidics Market Size & Outlook, 2026-2033
The microfluidics market in France is expected to reach a projected revenue of US$ 3,729.0 million by 2033. A compound annual growth rate of 10% is expected of France microfluidics market from 2026 to 2033.
In terms of revenue, France accounted for 4.1% of the global microfluidics market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Europe, UK microfluidics market is projected to lead the regional market in terms of revenue in 2033.
UK is the fastest growing regional market in Europe and is projected to reach USD 7,046.0 million by 2033.
In France, industry and public authorities have realized that microfluidics in advanced healthcare as well as research helps reduce environmental impact along with the associated costs. ESPCI ParisTech carries out fundamental research in distinctive areas jointly funded by various public authorities such as the Ministry of Higher Education and Research and the City of Paris.
Moreover, in May 2022. DEINOVE a French biotech company, was selected for the Boost-ID project, as part of the France Relance plan, with the operational installation of its microfluidic screening platform. Such activities can offer lucrative opportunities in the country during the forecast period.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Microfluidics Market Outlook will help companies and investors design strategic landscapes.
Microfluidic Components was the largest segment with a revenue share of 87.1% in 2025.
Horizon Databook has segmented the France microfluidics market based on microfluidic components, microfluidic-based devices covering the revenue growth of each sub-segment from 2021 to 2033.
In France, industry and public authorities have realized that microfluidics in advanced healthcare as well as research helps reduce environmental impact along with the associated costs. ESPCI ParisTech carries out fundamental research in distinctive areas jointly funded by various public authorities such as the Ministry of Higher Education and Research and the City of Paris.
Moreover, in May 2022. DEINOVE a French biotech company, was selected for the Boost-ID project, as part of the France Relance plan, with the operational installation of its microfluidic screening platform. Such activities can offer lucrative opportunities in the country during the forecast period.
France Microfluidics Market Product Outlook (Revenue, USD Million , 2021-2033)
Microfluidic Components
Microfluidic-based Devices
France Microfluidics Market Technology Outlook (Revenue, USD Million , 2021-2033)
Lab-on-a-Chip
Continuous Flow Microfluidics
Electrophoresis and Microfluidics
Acoustofluidics and Microfluidics
Optofluidics and Microfluidics
Organ-on-a-Chip
France Microfluidics Market Material Type Outlook (Revenue, USD Million , 2021-2033)
PDMS
Glass
Polymer
Silicon
Others
France Microfluidics Market Application Outlook (Revenue, USD Million , 2021-2033)
Medical
Non-medical
Reasons to subscribe to Microfluidics Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Microfluidics Market Outlook databook
Our clientele includes a mix of Microfluidics Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France Microfluidics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into France Microfluidics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.